SELLAS Life Sciences Group, Inc. SLS Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$26.86M+13.0% | -$30.88M+17.3% | -$37.34M+9.6% | -$41.3M-99.5% | ||
| $1.96M+25.1% | $1.56M-25.3% | $2.09M+21.3% | $1.73M+70.7% | ||
| —— | -$2.14M-193% | $2.3M+89.7% | $1.21M— | ||
| —— | —— | $1.45M-60.3% | $3.65M+402% | ||
| —— | —— | —— | -$1.25M— | ||
| $597K+6.4% | $561K+13.3% | $495K+8.3% | $457K— | ||
| -$635K-19.1% | -$533K-2.9% | -$518K-10.0% | -$471K— | ||
| -$28.39M+19.8% | -$35.4M-12.7% | -$31.41M-31.9% | -$23.81M+8.5% | ||
| —— | $0— | —— | $1.05M-88.4% | ||
| $527K+723% | $64K+106% | $31K— | $0— | ||
| $86.3M+84.6% | $46.76M+109% | $22.34M-7.2% | $24.08M+99.4% | ||
| $61.01M— | —— | -$14.6M-245% | -$4.23M— | ||
| -$635K-19.1% | -$533K-2.9% | -$518K-10.0% | -$471K— | ||
| —— | —— | —— | -$1.25M— | ||
| $597K+6.4% | $561K+13.3% | $495K+8.3% | $457K— | ||
| —— | $46.16M— | —— | —— | ||
| —— | —— | —— | —— | ||
| $12.62M+2,153% | $560K+3,900% | $14K— | $0-100% | ||
| —— | $0-100% | $103K— | $0— | ||
| -$635K-19.1% | -$533K-2.9% | -$518K-10.0% | -$471K— | ||
| $1.41M+123% | $632K+20.4% | $525K+65.6% | $317K+5,183% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does SELLAS Life Sciences Group, Inc. generate?
- SELLAS Life Sciences Group, Inc. (SLS) generated -$28.2M in operating cash flow over the trailing twelve months.
- Where does SELLAS Life Sciences Group, Inc.'s cash flow data come from?
- Every line is extracted from SELLAS Life Sciences Group, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.